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Abstract: Calcifying nanoparticles (CNPs) (nanobacteria, nanobacteria-like particles, nanobes) 
were discovered over 25 years ago; nevertheless, their nature is still obscure. To date, nobody has 
been successful in credibly determining whether they are the smallest self-replicating life form 
on Earth, or whether they represent mineralo-protein complexes without any relation to living 
organisms. Proponents of both theories have a number of arguments in favor of the validity of 
their hypotheses. However, after epistemological analysis carried out in this review, all arguments 
used by proponents of the theory about the physicochemical model of CNP formation may be 
refuted on the basis of the performed investigations, and therefore published data suggest a 
biological nature of CNPs. The only obstacle to establish CNPs as living organisms is the absence 
of a fairly accurately sequenced genome at the present time. Moreover, it is clear that CNPs 
play an important role in etiopathogenesis of many diseases, and this association is independent 
from their nature. Consequently, emergence of CNPs in an organism is a pathological, not a 
physiological, process. The classification and new directions of further investigations devoted 
to the role of CNPs in biology and medicine are proposed.
Keywords: nanobacteria, nanobacteria-like particles, diseases, infectious agents, 
hydroxyapatite
Introduction
Calcifying nanoparticles (CNPs) (nanobacteria, nanobacteria-like particles, nanobes) 
were discovered as cell culture contaminants by Kajander et al more than 25 years 
ago, and the first results of their work were published some years later.1 However, 
the question of their nature is actively discussed even at the present time. Despite 
recent investigations, as described in Table 1, there has not been a comprehensive 
study to credibly determine whether CNPs are the smallest self-replicating form of 
life on Earth, or whether they represent mineralo-protein complexes without any 
relation to bacteria. Proponents of both theories have a number of arguments, often 
mutually exclusive, in favor of the validity of their own hypotheses (Table 2), and 
at the present time the theory about CNPs being mineralo-protein complexes has 
the better hand.2–12 It is a challenge to collect all the existing information about the 
nature and basic properties of CNPs and to analyze it to compare the power of the 
arguments from both sides. Moreover, it seems to be useful to consider the role of 
CNPs in etiopathogenesis of various diseases, since several articles devoted to this 
problem have been published (see below). It can be crucially significant for medicine 
since CNPs can be absolutely new causative agents of many diseases and may 
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Table 1 Properties of CNPs
Properties of calcifying nanoparticles
Morphological properties 80–500 nm in diameter (can pass through 100 nm filters).1,16
Usually have coccoid, coccobacillar, or bacillar form, mineralized “igloo-like” structures.1,16
Have hydroxyapatite shell, cellular-membranous structure, and central cavity.1,16
Can form microscopic colonies (.1 mm in diameter) under low nutrient concentrations in the 
environment.1,16
Divide by binary fission, fragmentation, and gemmation.1,16
Can form thermoresistant biofilms1,16
Tinctorial properties Gram-negative; can be stained by DNA-specific dyes16–24 (Hoechst 33258 at a concentration of 5 μg/mL 
for 50 minutes, propidium iodide, PicoGreen – they are specific after the filtration through 0.10–0.22 μm 
pores, staining after demineralization is optimal); can be revealed by von Kossa staining;16 staining by 2% 
uranyl acetate (possibly with lead citrate) can detect specific mucus on the hydroxyapatite shell;1 in the 
mineralized state can be stained by alizarin red S;26 can be stained by phosphotungstic acid16
Resistance and sensitivity Resistant to 90°C heating for 1 hour.1
Resistant to γ-irradiation up to 30 kGray.1,16
Resistant to 5% NaCl solution.1
In the mineralized state are resistant to lysozyme, proteinase K, certain other proteinases, lipases, amylases, 
alkali, ultrasound, X-ray, detergents, and solvents.1
Temperatures under 37°C suppress replication and prevent biofilm formation.1
Resistant to a wide spectrum of antimicrobial therapeutics:30 aminoglycosides (in pharmacological 
concentrations), chloramphenicol, lincosamides, cephalosporins, macrolides, fluoroquinolones, 
glycopeptides (in pharmacological concentrations), polymyxins, antituberculous agents, aminocyclitol, 
spectinomycin.
Sensitive to tetracyclines,30 ampicillin,30 trimethoprim,30 trimethoprim-sulfamethoxazole,30 nitrofurantoin,30 
5-fluorouracil,30 cytosine arabinoside,30 antimycin A,22 sodium azide,22 potassium cyanide,22 bisphosphonates 
(etidronate, clodronate),30 6-aminocaproic acid;30 in-vitro growth can be inhibited by EDTA, EGTA, and 
citrate22
Culture properties Doubling time is 3 days; in media without serum, 6 days.1,16
Passage can be performed in DMEM or RPMI-1640 independently of the presence of serum.1,16
Optimal atmosphere for growth should contain 5% CO2 and 95% air.1,16
Sensitive to β-mercaptoethanol, which stimulates growth of anaerobes, but cannot be cultivated under 
strictly anaerobic conditions.22
Calcify when serum concentration in the culture media is lower than 5%.1
Cytotoxic for fibroblasts and lymphocytes16
Biochemical properties Metabolism is 10,000 times slower than in Escherichia coli.1
Incorporate uridine (into the expected nucleic acid),16,21 methionine16 and aspartic acid25 (into the expected 
system of protein biosynthesis).
Calcify under physiological pH (7.4).1,16
Urease negative16
Detection methods Bacterioscopic (DNA-specific dyes Hoechst 33258, propidium iodide, PicoGreen, staining after a 
demineralization is optimal) using scanning and transmission electron microscopy,16–24 von Kossa staining, 
which is specific to calcium compounds,16 staining by 2% uranyl acetate (possibly with lead citrate) to detect 
specific mucus on the hydroxyapatite shell,1 staining by alizarin red S in the mineralized state,26 staining by 
phosphotungstic acid,16 after the long-term cultivation light microscopy with von Kossa staining is possible 
to be used for detection.1,16
Bacteriological (cultivation in DMEM or RPMI-1640 without serum under 37°C for 4–6 weeks after 
filtration through 0.10–0.22 μm pores),1,16 replication can be assessed by spectrophotometry (650 nm 
wavelength).16
Serological (CNP antigens and anti-CNP monoclonal antibodies 8/0 [to porin],17,20 5/2 [to peptidoglycan],17,20 
and 8D10 [to porin]21,32,43 of NanoBiotech Pharma, Tampa, FL) – ELISA,43 immunohistochemistry,32 
immunofluorescence reaction,32 immunoblotting, Ouchterlony immunodiffusion.20
Genomic (PCR), but there is doubt that existing primers are obtained on the basis of CNP nucleic acids, 
and not on the basis of nucleic acids of contaminating bacteria.2
Proteomic (sodium dodecyl sulfate polyacrylamide gel electrophoresis with further identification of protein 
bands by mass spectrometry)22
Methods of treatment  
of CNP-associated diseases
comET-therapy (tetracycline, EDTA, and mixture of nutrients)36,41
Abbreviations: CNP, calcifying nanoparticles; DMEM, Dulbecco’s modified Eagle’s medium; EDTA, ethylenediaminetetraacetic acid; EGTA, ethyleneglycoltetraacetic acid; 
ELISA, enzyme-linked immunosorbent assay; PCR, polymerase chain reaction; RPMI-1640, Roswell Park Memorial Institute 1640 medium.
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  determine their course, affecting rapidity, severity, therapeu-
tic resistance and sensitiveness, and prognosis of mentioned 
disorders. The main aims of this review were to perform an 
analysis of the role of CNPs in biology and medicine from 
a fundamental and clinical point of view, to describe and to 
analyze the situation in the field, and to determine new direc-
tions for further investigations. To the best of the authors’ 
knowledge, this review comprises all published articles on 
the abovementioned topic.
CNPs – physicochemical 
phenomenon or bacteria?
A more thorough analysis of existing arguments may reveal 
the following:
•	 According to the research of Maniloff,13 the smallest pos-
sible size of a self-replicating life form is approximately 
140 nm, but results of an investigation performed by 
Glass et al14 have shown that Mycoplasma laboratorium 
may reach even smaller sizes, having only 387 protein-
coding genes and 43 RNA-coding genes, which is enough 
for independent existence. Moreover, according to the 
calculations of Volke,15 if water in a cell is reduced from 
70% (as in Mycoplasma spp.) to 20%, the size of the 
bacterial cell may shrink to 75 nm whilst its viability 
would still be maintained. Therefore, CNPs being life 
forms cannot be ruled out based on their extremely 
small size alone. Also, it is not possible to rule out the 
uniqueness of the replicative and metabolic mechanisms 
Table 2 Arguments supporting and contradicting the hypothesis that CNPs are nanobacteria, a unique form of life on Earth
Arguments in favor of theory that  
CNPs are living organisms (nanobacteria)
Arguments in favor of theory that CNPs are a physicochemical   
phenomenon (mineralo-protein complexes)
Morphological similarity to bacteria,  
cultivation on various media, binary fission16
Extremely small size (often smaller than 140 nm – presumably  
minimum possible size limit of life forms)
Staining by DNA-specific dyes  
(Hoehst 33258, propidium iodide, PicoGreen)16–24
Absence of fairly accurately sequenced genome
Presence of DNA and RNA in ratio characteristic  
for Escherichia coli19,22
Identification of DNA and RNA by electron microscopy49
Incorporation of [35S]methionine,16 [3H]L-aspartic acid,25  
and [5-3H]uridine during cultivation16,21
Association of hydroxyapatite of CNPs with albumin,6,8–10  
fetuin-A,5,9,10 apolipoproteins,9,10 proteins of coagulation and 
anticoagulation systems,9,10 immunoglobulins,9,10 macroglobulins,9,10 
complement proteins,9,10 precursors of interleukins,10 kininogen,9,10 
fibronectin,9,10 vitronectin,9,10 vitamin D-binding protein,9,10 precursor 
of antitrypsin,9,10 serotransferrin,10 syntrophin,9,10 Tamm-Horsfall 
glycoprotein,10 glycogenin,10 serum component of amyloid,10 salivary 
amylase,10 cytoskeleton proteins,9 adenosylhomocysteinase,9 
hemoglobin subunits9 and other proteins
The presence of endotoxin and cross-reactivity with  
lipopolysaccharide of Chlamydia spp. and with antigens  
of Bartonella spp18
Cross-reactivity of MoAbs to presumably specific CNP proteins  
with serum proteins – albumin6,8–10 and fetuin-A5,9,10
Susceptibility to a number of antimicrobial chemotherapeutics  
possessing antimetabolic activity and not possessing the  
chelating activity,30 (nitrofurantoin, trimethoprim,  
trimethoprim-sulfamethoxasole), to 5-fluorouracil,  
cytosine arabinoside, 6-aminocaproic acid,30  
antimycin A, sodium azide, potassium cyanide22
Morphological similarity to various mineral and mineralo-protein 
complexes containing inorganic calcium, phosphorus, and apatite 
compounds, and also proteins and phospholipids2,6,8–10
Acceleration of replication and reduction of formation of biofilms  
after photobiostimulation29
Resistance to DNase and RNase activity5
Presence of proteins, including bacterial ones, after  
a demineralization16,20,21 (EF-Tu,22,26 EF-G,26 GroEL,22  
dihydrolipoamide acetyltransferase of pyruvate dehydrogenase,22  
polyribonucleotide nucleotidyl transferase,22 fructose  
binding aldolase,26 chaperone C1pB26)
Critical influence of inert gas, CO2, and NaHCO3 concentration  
on CNP replication6
Stimulation of replication by β-mercaptoethanol and absence  
of replication under strictly anaerobic conditions22
CNP formation under physiological serum conditions after certain 
physiological alterations of homeostasis, which is not characteristic  
of living organisms5–10
Pathogenic activity of demineralized CNPs31 and distinct  
pathogenicity of CNPs and hydroxyapatite crystals23
Abbreviations: CNP, calcifying nanoparticle; MoAb, monoclonal antibody; EF-Tu, elongation factor thermo unstable; EF-G, elongation factor G.
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of CNPs requiring a smaller size for proper functioning, 
and these mechanisms can feasibly be characterized by 
a greater compactness compared with their analogs in 
other organisms.
•	 Although the genome of CNPs is still not credibly 
deciphered (although in certain studies the sequencing 
was conducted, it is possible to suspect a contamination of 
analyzed samples by another bacteria, eg, Phyllobacterium 
myrsinacearum2), a number of investigations have shown 
positive DNA-specific staining of CNPs.16–24 Furthermore, 
Hudelist et al19 and Kumar et al22 were successful in 
extracting DNA and RNA from CNPs, indicating the 
presence of nucleic acids. The suggestion that nucleic 
acids are only bound to highly charged molecules 
of mineralo-protein complexes outside and are not 
synthesized in CNPs12 can be disproved by the results of 
Ciftçioglu et al,17 Khullar et al,20 Miller et al,21 and Kumar 
et al,22 who observed DNA-specific staining of already 
demineralized CNPs, which could not have been possible 
in the case of a simple binding of nucleic acids outside 
by a mineralo-protein shell. In addition, Kajander and 
Ciftçioglu16 and Miller et al21 have shown incorporation 
of [5-3H]uridine by CNPs during cultivation, suggesting 
that CNPs have metabolism and produce their own 
nucleic acids. Indirect testimony of this fact is that 
Kajander and Ciftçioglu16 and Puskas et al25 revealed 
incorporation of [35S]methionine and [3H]L-aspartic 
acid, respectively, by CNPs during incubation, proving 
the presence of their own system of protein biosynthesis, 
which is impossible without nucleic acids. One more 
argument in favor of the validity of such a statement is 
an identification among proteins that are characteristic for 
CNPs, elongation translation factors (elongation factor 
thermo unstable [EF-Tu]22,26 and elongation factor G 
[EF-G]26), polyribonucleotide nucleotidyl transferase,22 
and chaperones GroEL22 and C1pB,26 which are similar 
to their prokaryote analogs. Published data suggest with 
high probability that CNPs have intrinsic nucleic acids 
(and, consequently, their own replication system) and an 
intrinsic protein biosynthesis system.
•	 Although proteomic analysis carried out in certain 
studies5,8–10 revealed a number of serum proteins in 
the composition of CNPs and did not find specific 
bacterial proteins, allowing the conclusion that these 
complexes have a mineralo-protein nature, data obtained 
by Kajander and Ciftçioglu,16 Khullar et al,20 Miller 
et al,21 Kumar et al,22 and Shiekh et al26 counter this 
suggestion since in indicated investigations bacterial 
proteins were identified in the structure of CNPs. The 
suggestion of there being an occasional association of 
these proteins with the   mineralo-protein shell of CNPs is 
contradicted by   studies by Khullar et al,20 Miller et al,21 
Kumar et al,22 and Shiekh et al,26 since in these studies, 
protein composition of already demineralized CNPs 
was analyzed. It is important to note that all proteins 
detected in the investigations of Kumar et al22 and Shiekh 
et al26 are bacterial and are related only to the replication 
system (polyribonucleotide nucleotidyl transferase22), 
the protein biosynthesis system (EF-Tu,22,26 EF-G,26 
chaperones GroEL22 and C1pB26), or the metabolic 
system (dihydrolipoamide acetyltransferase of pyruvate 
dehydrogenase22 and fructose binding aldolase26), which 
is consistent with the hypothesis that CNPs have only 
a limited number of intrinsic proteins, and all of them 
belong only to vitally important systems. Moreover, 
incorporation of [35S]methionine16 and [3H]L-aspartic 
acid25 by CNPs during cultivation, as discussed above, 
points to the presence in CNPs of their own system 
of protein biosynthesis. As a consequence, proteomic 
analysis also verifies the theory of CNPs being the 
smallest self-replicating life forms on Earth.
•	 Cross-reactivity of monoclonal antibodies (MoAbs) 
to putative specific proteins of CNPs (porin and 
peptidoglycan) with serum proteins (albumin6,8–10 and 
fetuin-A5,9,10) revealed in a number of studies, according 
to the opinion of their authors, has shown a falsity of 
the conclusions obtained in former investigations in 
which these MoAbs were used. However, it can explain 
only negative results obtained in studies devoted to the 
relation between the level of CNP antigens and anti-CNP 
antibodies and the features of various diseases, whilst in 
almost all papers (Table 3), on the contrary, positive results 
were obtained. A permanent cross-reaction is not possible, 
since albumin and fetuin-A can always be detected in 
serum under normal conditions, and thus CNP antigens 
should be revealed in the serum of nearly all subjects. In 
reality, however, this was not found to be the case (only 5% 
of positive subjects in the Finnish population27). Applied 
MoAbs thereby have sufficient levels of specificity, and 
consequently, their cross-reactions with albumin and 
fetuin-A cannot prove an absence of suggested bacterial 
proteins (porin and peptidoglycan) in their composition, 
as was proposed in articles by Wu et al,8 Young et al,9,10 
Raoult et al,5 and Martel and Young.6
•	 Morphological similarity of CNPs to various mineral and 
mineralo-protein complexes2,6 cannot be an argument 
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for their physico-chemical nature since they are equally 
similar to bacteria.16 Besides, morphology itself cannot 
explain the nature of CNPs and should not be used by 
proponents of both theories as objective testimony.
•	 Raoult et al5 proposed that CNPs do not contain nucleic 
acids since in their investigation they were resistant 
to DNAse and RNAse, continually replicating inde-
pendently of the presence of these enzymes in culture 
medium.   Nevertheless, it can be explained by the protec-
tive role of the mineral shell of CNPs since preliminary 
demineralization was not carried out. Furthermore, 
after demineralization, replication of CNPs ceases or 
decreases sharply,26 which makes assessment of the 
influence of DNAse and RNAse upon it very difficult. 
Therefore, resistance of CNPs to the action of nucleases 
found in this research cannot be an argument in favor of 
their physicochemical nature.
•	 Martel and Young6 revealed that characteristics of CNP 
replication directly depend on the atmosphere of cul-
tivation (in an atmosphere containing 100% inert gas, 
replication is higher than in one containing 5% CO2 or 
100% CO2) and on NaHCO3 concentration in culture 
medium (when it is high, replication accelerates; when 
it is low, it slows). These results enabled the authors of 
that study to propose a chemical model of CNP formation 
on the basis of certain reaction equations, which accord-
ing to their opinion, completely subverted the theory of 
their biological nature.6 However, this model explains 
only the formation of the CNP mineral shell and is not 
related to the presence or absence of nucleic acids in 
their   structure. Also, published data indicate the impos-
sibility or almost complete cessation of CNP replication 
without a mineral shell,26 which proves the necessity of 
the presence of nucleic acids and proteins as a mineral 
shell for successful replication. The model suggested 
by Martel and Young6 does not contradict but affirms 
this   hypothesis: when conditions for a mineral shell (the 
lion’s share of which consists of calcium compounds, 
particularly of calcium phosphate and carbonate) for-
mation are not appropriate, CNP replication ceases or 
sharply decreases; whilst under conditions promoting its 
formation, CNP replication is enhanced. This chemical 
model logically corresponds with the theory of CNPs 
being the smallest self-replicating life forms.
•	 In a number of studies,5–10 it has been proposed that 
CNPs may be formed under physiological conditions of 
serum (even of γ-irradiated serum7) as mineralo-protein 
complexes during certain alterations in homeostasis 
within normal limits, and consequently, they cannot be 
live objects. Nevertheless, Mathew et al28 indicated that 
CNPs may successfully replicate even in the absence of 
serum, which points to independence of their replication 
from serum proteins. It is important to note that inorganic 
hydroxyapatite crystals did not replicate independently of 
the presence of serum in culture medium in this research, 
and CNPs were not observed in control serum-containing 
media under the same culture c  onditions.28 Moreover, 
in epidemiological studies devoted to the association of 
CNPs with risk of various diseases (Table 3), CNP anti-
gens and anti-CNP antibodies were detected significantly 
more often in cases compared with controls. (See the 
discussion about the specificity of CNP antigens and of 
MoAbs to bacterial proteins of CNPs above.)   Furthermore, 
Khullar et al,20 Miller et al,21 Kumar et al,22 and Shiekh 
et al26 found bacterial proteins that are absent in serum 
under physiological conditions in the composition of 
demineralized CNPs. All these data, evidently, contradict 
the hypothesis of CNPs being physicochemical complexes 
formed from ubiquitous minerals and proteins of serum 
and other biological liquids under homeostasis condi-
tions, countering the theory proposed by Raoult et al,5 
Martel et al,6,7 Wu et al,8 and Young et al.9,10   Obviously, 
emergence of CNPs in the organism is a pathological, not 
physiological, process.
Thereby, all arguments used by proponents of the 
theory of CNPs being mineralo-protein complexes (ie, the 
physicochemical model of CNP formation) may be refuted 
on the basis of investigations carried out. Moreover, the 
fact that Hjelle et al18 revealed cross-reactivity of MoAbs 
to CNP bacterial proteins (porin and peptidoglycan) with 
lipopolysaccharide of Chlamydia spp. and with antigens 
of Bartonella spp., which points to the presence of similar 
bacterial proteins in the CNP structure, testifies against this 
hypothesis as well. A stochastic association of these proteins 
with mineralo-protein complexes is excluded, since it is 
absolutely impossible that they could be bound to CNPs in 
the majority of examined samples. Furthermore, replicative 
activity of CNPs increases during photobiostimulation29 
and during exposure to β-mercaptoethanol,22 indicating 
their biological nature (characteristics of replication of 
mineralo-protein complexes during such influence are not 
elevated). Without oxygen, CNPs do not replicate.22 Taking 
into account that β-mercaptoethanol stimulates the growth of 
aerobes,22 it is possible to suggest that CNPs are facultative 
anaerobes or microaerophilic microorganisms. Susceptibil-
ity of CNPs to a number of chemotherapeutics possessing 
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antimetabolic   activity, suppressing biosynthesis of nucleic 
acids and proteins as well as respiratory enzyme functioning 
(  nitrofurantoin, trimethoprim, trimethoprim-sulfamethoxa-
sole, 5-fluorouracil, cytosine arabinoside, 6-aminocaproic 
acid, antimycin A, sodium azide, potassium cyanide) and 
not possessing the chelating activity,30 can also be testimony 
of the presence of their own system of replication, protein 
biosynthesis, and metabolism, which points to their biological 
nature. Finally, CNPs may cause pathological processes in 
blood vessels even without a mineral shell;31 this may indi-
cate the presence of specific immunogenic bacterial protein 
antigens in their structure, and also, these proteins may have 
toxin-like activity. The ability of hydroxyapatite crystals 
to cause the formation of black pigment gallstones after an 
injection into rabbit gallbladder was several times lower than 
with the injection of CNPs,23 which points to additional CNP 
pathogenic mechanisms and contradicts the hypothesis of an 
inorganic nature and indicates a biological origin.
Published data suggest a biological nature of CNPs, 
making valid the term “nanobacteria,” originally proposed 
by Kajander et al.1 The only obstacle in establishing CNPs 
as living organisms is an absence of a fairly accurately 
sequenced genome at the present time, but it itself is not 
able to counter the theory that they are the smallest self-
replicating life forms on Earth in favor of the theory that 
they are physicochemical mineralo-protein complexes.
The role of CNPs in 
etiopathogenesis of diseases
Many studies in the literature show the significant role of 
CNPs in the etiopathogenesis of various diseases, particularly 
of disorders related to pathological calcification (Table 3). 
Martel et al7 hypothesized that it is incorrect to apply widely 
used γ-irradiated serum as a component of culture medium for 
CNPs since the γ-irradiation that is used for serum steriliza-
tion does not in fact have a sterilizing effect. However, all 
Table 3 The relation of CNPs to various diseases
Study Disease or pathological condition Method of detection of association between CNPs 
and disease or pathological condition
Kajander and Ciftçioglu16 Nephrolithiasis Serological, bacterioscopic, bacteriological
Ciftcioglu et al17 Nephrolithiasis Serological, bacterioscopic, bacteriological
Hjelle et al18 Polycystic kidney disease Serological, bacterioscopic, bacteriological
Sedivy and Battistutti46 Formation of psammoma bodies in ovarian malignant  
tumors
Serological
Hudelist et al19 Formation of psammoma bodies in ovarian malignant  
tumors
Serological
Khullar et al20 Nephrolithiasis Serological, bacterioscopic, bacteriological
Maniscalco et al41 Coronary artery calcification Serological
Miller et al21 Calcification of coronary arteries and cardiac valves Serological, bacterioscopic, bacteriological
Pretorius et al48 HIv infection Serological
Puskás et al25 Atherosclerotic plaques Serological, bacterioscopic, bacteriological
Shoskes et al36 Type III chronic prostatitis/chronic pelvic pain syndrome Serological
wen et al47 Cholecystolithiasis Serological, bacterioscopic, bacteriological
Kumar et al22 Randall’s plaques Serological, bacterioscopic, bacteriological
Shiekh et al26 Renal tubular calcification Bacteriological (animal model)
wang et al23 Black pigment gallstones Serological, bacterioscopic, bacteriological (animal model)
Agababov et al49 Pathological placental calcification Bacterioscopic
Bratoz-Perez et al42 Aortic valves calcification Bacterioscopic, bacteriological
Ciftcioglu et al32 Randall’s plaques Serological, bacterioscopic, bacteriological
Schwartz et al31 Calcification of arteries with damaged endothelium Bacterioscopic, bacteriological (animal model)
Zhou et al37 Type III prostatitis Serological, bacterioscopic, bacteriological
Candemir et al43 Mitral annular calcification Serological
Chen et al33 Nephrolithiasis Serological, bacterioscopic, bacteriological
Hu et al44 Calcification of cardiac valves during rheumatic  
heart disease
Serological, bacterioscopic, bacteriological
Hu et al34 Nephrolithiasis Bacterioscopic, bacteriological (animal model)
Shen et al38 Type III prostatitis Bacterioscopic, bacteriological (animal model)
Zhang et al39 Interstitial cystitis/painful bladder syndrome Serological, bacterioscopic, bacteriological
Zhang et al40 Testicular microlithiasis Serological, bacterioscopic, bacteriological
Tulunay Kaya et al45 Coronary artery calcification Serological
Abbreviations: CNP, calcifying nanoparticle; HIV, human immunodeficiency virus.
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other studies that are mentioned below show that γ-irradiation 
of similar dose successfully copes with its role of prevent-
ing CNP formation in control media (hence, it sterilized the 
serum in all media). Also, Mathew et al28 found that CNPs 
are able to be cultivated even in media without serum.
The first and the most investigated is the connection of 
CNPs with risk of nephrolithiasis that was shown in 1998 
by Kajander and Ciftçioglu,16 who revealed specific CNP 
antigens in all 30 examined kidney stones, and who also 
extracted and cultivated CNPs from these samples. These data 
were further proved in the investigation of Ciftçioglu et al,17 
who indicated CNPs in 97.2% of examined kidney stones 
by several methods (eg, immunostaining, assessment of Ca 
and 85Sr incorporation, and bacterioscopic and bacteriologi-
cal methods). Moreover, based on the following statements, 
they proposed a theory that CNPs are an etiological agent 
of nephrolithiasis.17
•	 CNPs were identified, extracted and cultured from the 
vast majority of kidney stones.
•	 Almost all kidney stones contained apatite, which is a 
component of CNP mineral shell.
•	 CNPs are the only known agent producing apatite and 
depositing in the kidneys.
•	 CNPs that were extracted and cultured from kidney stones 
formed new ones during incubation.
•	 CNPs labeled by radioactive technetium (99mTc) and 
intravenously injected into rabbits were renotropic and 
could be found in the urine.
•	 The results of similar studies conducted in distinct popula-
tions (Finnish and American) were close to each other.
This hypothesis was proved by Khullar et al,20 who 
identified CNPs in 62% of kidney stones in an Indian 
population using serological (Ouchterlony immunodiffusion 
test), bacterioscopic, and bacteriological methods. Kumar 
et al22 exploited serological, bacterioscopic, bacteriological, 
genomic, and proteomic assays and noted a probable role 
of CNPs in etiopathogenesis of Randall’s plaques that are 
precursors of kidney stones of calcium oxalate.   Subsequently 
their results were confirmed by Ciftçioglu et al,32 who 
detected CNPs in ∼70%–90% of kidney papillae samples 
afflicted by Randall’s plaques serologically, bacterioscopi-
cally, and bacterologically (tests that were carried out had 
different sensitivity and specificity). Similar results were 
obtained during the analysis of serum from these patients.32 
Furthermore, Chen et al33 indicated the presence of CNPs 
in the serum of 92% of patients with nephrolithiasis and the 
absence of them in the serum of control subjects, but it should 
be noted that the sample size was insufficient (24 cases and 
three controls). Hu et al34 demonstrated the ability of CNPs 
to cause nephrolithiasis in rats, and tetracycline possessed a 
specific antibacterial activity (inhibition of protein synthesis) 
as chelating activity prevented formation of kidney stones 
in this study. Earlier similar results were obtained in rats by 
Shiekh et al,26 but the number of rats in their investigation 
was too small (three cases and three controls). Moreover, the 
influence of tetracycline on kidney stone formation was not 
assessed in their study.26
In relation to other kidney diseases, Hjelle et al18 found 
CNPs in kidneys of patients with polycystic kidney disease 
by bacterioscopic and serological methods in 100% of cases 
(eight cases out of eight, and 13 cases out of 13, respectively), 
and by bacteriological assays – in 84.6% of cases (eleven 
cases out of 13). The role of CNPs in etiology of this disorder 
remains unclear since there were no similar studies from 
that time, but it is known that nephrolithiasis is diagnosed in 
patients with polycystic kidney disease several times more 
often than in the general population.35
Also, the role of CNPs in etiopathogenesis of type III 
chronic prostatitis/chronic pelvic pain syndrome was inves-
tigated. Shoskes et al36 found that comET therapy (tetracy-
cline + ethylenediaminetetraacetic acid [EDTA] + nutrients) 
for 3 months leads to at least a 25% improvement of condi-
tions in 80% of patients with this disorder (according to the 
National Institute of Health Chronic Prostatitis Symptom 
Index) resistant to other therapeutic modalities, and in 53% 
of cases this parameter was higher than 50%. The size of 
stone decreased at least twofold in 50% of patients according 
to the results of a transrectal ultrasound test.36 CNP antigens 
and anti-CNP antibodies were also detected in 60% of serum 
samples and in 40% of urine samples.36 In 2008, Zhou et al37 
carried out a placebo-controlled trial of therapy against 
CNPs on a larger sample of patients with type III chronic 
prostatitis resistant to other treatment. After the course of 
therapy, according to bacterioscopic and bacteriological 
methods, CNPs were found in expressed prostatic secre-
tions of only 16.7% of patients (before treatment this rate 
was 62.5%); whilst in the urine, CNPs were not detected 
at all (before treatment this parameter was 12.5%).37 In a 
group of subjects who received placebo, no statistically sig-
nificant decline of CNP detection rate was noted.37 Similar 
results were obtained in relation to the improvement of the 
condition of patients (according to the National Institute of 
Health Chronic   Prostatitis Symptom Index).37 This led to the 
suggestion that CNPs play a role in the etiology of type III 
chronic prostatitis, and an effective method of treatment of 
this disease was proposed.37 Finally, in 2010, Shen et al38 
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demonstrated the influence of CNPs on the development of 
type III chronic prostatitis on the animal model, injecting 
CNPs into rats transurethrally. After 1–2 weeks from the 
beginning of the experiment, prostatic acute inflamma-
tory changes were observed in rats exposed to CNPs; after   
4 weeks, these inflammatory alterations became chronic.38 
After the end of the 8th week, 70% (7 out of 10) of the rats 
had microscopic calculi in the prostatic glandular cavity.38 
Nothing of significance was detected in the control rats.38 
The level of interleukin-1β and tumor necrosis factor-α in 
the prostate of model rats was higher than in control rats at 
all time points.38 The role of CNPs in the etiology of type III 
chronic prostatitis was thereby confirmed experimentally.38
In relation to other diseases of the genitourinary tract, 
Zhang et al39 proposed a role of CNPs in the etiology of inter-
stitial cystitis/painful bladder syndrome and revealed them by 
serological, bacterioscopic, and bacteriological assays CNPs 
in 47.8% (11 out of 23) of bladder tissue samples of patients 
with this disorder, also demonstrating significant improve-
ment of symptoms (up to complete convalescence) in 90.9% 
(10 out of 11) of these patients after tetracycline treatment 
(orally and intravesically). Moreover, after such therapy CNPs 
were detected in the bladder tissue in only 27.3% of cases (3 
out of 11).39 The same authors hypothesized a feasible role of 
CNPs in the etiology of testicular microlithiasis and observed 
CNPs using serological, bacterioscopic, and bacteriological 
tests in 58.8% (10 out of 17) of semen samples of patients 
with this disease compared with 5.9% (1 out of 17) of con-
trols.40 Summing up, it is possible to conclude that CNPs 
play an important role in the development of the various 
diseases of the genitourinary tract, particularly affecting the 
risk and the course of nephrolithiasis and of type III chronic 
prostatitis/chronic pelvic pain syndrome.
A number of researchers have investigated the influence 
of CNPs on the etiopathogenesis of cardiovascular diseases. 
Maniscalco and Taylor41 serologically revealed that comET 
therapy (1500 mg of EDTA in a rectal suppository base, 
500 mg of tetracycline orally, and a mixture of various 
nutrients in powder orally; all indicated every evening) for 
4 months may be effective against coronary artery disease, 
decreasing calcification of coronary arteries, which is 
presumably caused by the deposit of CNPs within them 
(it is known that CNPs are as sensitive to tetracycline as 
they are to EDTA). Miller et al21 found CNPs serologically, 
bacterioscopically, and bacteriologically in calcified 
aneurysms, cardiac valves, and plaques of carotid and femoral 
arteries, but did not detect them in noncalcified aneurysms, 
concluding that CNPs may cause calcification of cardiac 
valves and blood vessels. Similar results were obtained by 
Puskas et al,25 who serologically identified CNPs in 64.3% (9 
out of 14) of atherosclerotic plaques of carotid arteries and 
aorta, but did not observe them in five control samples of 
the same vessels. Furthermore, they successfully extracted 
and cultivated CNPs from 26 out of 42 calcified sclerotic 
samples of aortas and carotid arteries, which suggests their 
involvement in atherosclerosis etiology (particularly at the 
stage of blood vessel calcification).25   Bratoz-Perez et al42 
detected CNPs in 48 out of 75 aortic valves with stenosis 
(64%) by bacterioscopic and bacteriological methods, and 
did not reveal them in healthy valves (0 out of 8). In 2008, 
Schwartz et al31 demonstrated CNP toxicity for arteries in the 
animal model (rabbits). Damaging carotid arteries on the one 
side and using contralateral carotid arteries as controls, they 
tested them for susceptibility to exposure to intravenously 
injected saline, mineralized CNPs, or demineralized CNPs.31 
  Damaged arteries exposed to mineralized CNPs were 
occluded, sometimes with canalization, and mineralized CNPs 
from kidney stones formed calcifications inside occluded 
vessels.31 Demineralized CNPs from kidney stones induced 
minimal eccentric intima hyperplasia in damaged arteries (as 
saline), whilst demineralized CNPs from calcified arteries 
caused moderate hyperplasia or occlusion with canalization 
and calcifications.31 CNPs may therefore lead to occlusion 
and calcification of damaged arteries,31 and it is important that 
they can induce pathological processes in blood vessels even 
without a mineral shell (see above). Arteries with healthy 
endothelium were resistant to exposure to CNPs.31 Candemir 
et al,43 in an epidemiological investigation by enzyme-linked 
immunosorbent assay (ELISA) found a connection between 
the level of anti-CNP antibodies and the risk of mitral 
annular calcification and with the thickness of calcification, 
suggesting the following mechanisms of this association:
•	 Colonization of mitral valve by CNPs induces an immune 
response, promoting inflammation development and 
further calcification, closing the “vicious circle.” CNPs 
may also form calcifications in adjacent tissues on their 
own after the colonization.
•	 CNPs may alter the composition and quantity of micro-
flora in the place of colonization that may lead to bacte-
rial infection and to formation of biofilms. Furthermore, 
calcification itself promotes colonization of afflicted 
tissue by other possibly pathogenic bacteria.
Hu et al44  serologically,  bacterioscopically  and 
  bacteriologically found a connection between CNPs and the 
calcification of cardiac valves during rheumatic heart disease. 
In their study, CNPs were identified in 89.6% of calcified 
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samples (26 out of 29) and in none of control   samples.44 
Finally, Tulunay Kaya et al45 used ELISA to show the asso-
ciation between the level of anti-CNP antibodies and the risk 
and severity of calcification of coronary arteries. Results of 
all studies devoted to the relation of CNPs with pathological 
calcification of cardiac valves and blood vessels suggest that 
this connection probably exists.
In a number of studies, the connection of CNPs with 
other diseases associated with pathological calcification has 
also been investigated. Sedivy and Battistutti46 found CNP 
antigens in 100% (7 out of 7) of ovarian malignant tumors 
in which psammoma bodies (which are microcalcifications) 
were detected, whilst in samples without such microcalcifica-
tions these antigens were not observed.46 Their results were 
completely proved by Hudelist et al,19 who identified CNP 
antigens in eight out of eight ovarian neoplasms containing 
psammoma bodies, and did not detect them in ten out of ten 
tumors without these microcalcifications. Interestingly, in 
this investigation, the extraction of mRNA of CNPs from 
all tumor samples with psammoma bodies was successful, 
whilst all attempts to do this in the cases with tumors without 
psammoma bodies failed.19 Wen et al47 have shown that CNP 
antigens are significantly more often detected in the serum 
of patients with cholecystolithiasis (31.6%) compared with 
control group (8%). Moreover, it was observed that the 
gallbladder mucosa is infected by CNPs during cholecysto-
lithiasis in 35% of cases.47 Of interest, 42.5% of patients had 
CNP antigens in their bile but not their gallbladder mucosa, 
which suggests that gallbladder mucosa has the ability to 
prevent CNP infiltration, but when CNPs invade the mucosa 
and submucosa, they may form calcifications and cause gall-
bladder fibrosis.47 Wang et al23 observed that CNPs, extracted 
from the bile of patients with cholecystolithiasis, may cause 
formation of black pigment gallstones in rabbits after the 
intravesical injection in 80% of cases (eight out of ten), whilst 
hydroxyapatite crystals and culture media for CNPs led to 
the occurrence of such gallstones only in 20% of cases (two 
out of ten). These authors therefore concluded that CNPs can 
be a cause of cholecystolithiasis (particularly in the case with 
black pigment gallstones), and inorganic hydroxyapatite 
crystals are not equivalent to CNPs in the ability to induce 
this pathological condition,23 which is consistent with the 
results of Schwartz et al,31 who have also shown in an animal 
model that hydroxyapatite cannot be fully responsible for 
pathogenic activity of CNPs.
Pretorius et al48 investigated the prevalence of CNP anti-
gens and anti-CNP antibodies in human immunodeficiency 
virus (HIV)-infected women and healthy women in South 
Africa. According to the results of their study, anti-CNP 
antibodies and CNP antigens were found in 85% and 7.5% 
of HIV-infected women, respectively, whilst in the control 
group these rates were 5% for both CNP antigens and anti-
CNP antibodies.48 Interestingly, amongst the offspring of 
HIV-infected mothers, 70% had CNP antigens according to 
the results of ELISA, and antigen levels in their blood was 
higher compared with the mothers.48 Two HIV-positive babies 
were characterized by the highest level of these antigens in 
the blood, and blood of their mothers also contained CNP 
antigens.48 Based on the results, the authors proposed an 
opportunistic nature of CNP invasion,48 and also proposed 
the possibility of transplacental or perinatal transmission of 
CNPs from mothers to offspring. Finally, the feasible role of 
CNPs in the etiology of pathological placental calcification 
was shown bacterioscopically.49
Conclusion
This epistemological analysis shifts the balance between 
the two hypotheses (the physicochemical and the biological 
nature of CNPs) in favor of the biological one, making the 
term “nanobacteria” relevant again, but at the same time it is 
obvious that discussions about the nature of CNPs will con-
tinue until their genome can be fairly accurately sequenced. 
However, it is clear that CNPs play an important role in the 
etiopathogenesis of many diseases, and this connection is 
independent of their nature, although results of conducted 
epidemiological studies and experimental investigations 
on animal models prove their biological origin. Hence, the 
emergence of CNPs in the organism is a pathological, not 
a physiological, process. Thereafter, the actual problem of 
studying CNPs is the development of effective methods of 
etiotropic treatment of diseases related to them, and also the 
development of specific preventive measures and diagnostic 
assays. Existing serological tests are suspected in the insuffi-
cient specificity because of cross-reactivity of MoAbs to CNP 
antigens with proteins of biological liquids, bacterioscopic 
methods are too difficult, expensive and labor-intensive, 
and bacteriological assays require too long a time for their 
  conduction. The relevance of genomic method (polymerase 
chain reaction) is doubtful because of problems with speci-
ficity of existing primers to putative nucleotide sequences of 
CNPs, and the development of proteomic assays is only at the 
early stages. The prospective directions are the development of 
more specific CNP antigens and anti-CNP MoAbs, and also 
the development of new media for accelerated CNP cultiva-
tion (it can also facilitate the usage of bacterioscopic method 
as microscopic colonies of CNPs can be analyzed by light 
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microscopy with von Kossa staining, which is more available 
and cheaper than electron microscopy). Correct sequencing 
of the CNP genome will definitely lead to the appearance of 
specific primers and to the development of genomic CNP-
related assays. Also, further investigations devoted to the 
exploration of sensitivity and resistance of CNPs to various 
antimicrobial chemotherapeutics, used in medical practice 
for therapy and disinfection, are needed. The possibilities for 
the prevention of CNP-associated diseases can be optimally 
analyzed from ecological and hygienic as well as from chemo-
preventive points of view. Such complex measures should 
reduce economic losses, incidence, disability, and mortality 
from CNP-associated diseases, and also increase quality of 
life of these patients. It is obvious that to reach this aim, basic, 
translational, and clinical studies are necessary.
Further investigations in the CNP research field may be 
classified as follows:
•	 Fundamental studies that are focused on the extraction 
of CNP nucleic acids with subsequent sequencing of 
their genome, which will prove they are the smallest 
self-replicating life form on Earth, and to the studying 
of various properties of CNPs, including pathogenic 
ones. Many already performed basic investigations (for 
instance, those where the presence of DNA in CNPs 
was proved by positive DNA-specific staining, but DNA 
was not extracted)17,18,20,21,23,24 are close to this group, and 
they can be represented as “first generation” studies. 
Investigations by Hudelist et al19 and Kumar et al22 may 
be represented as prototypes for further investigation 
(in another words, they can be represented as “second 
generation” studies), since CNP nucleic acids were suc-
cessfully extracted, although accurate sequencing was not 
conducted. Consequently, investigations in which fairly 
accurate sequencing of the CNP genome will be carried 
out will represent “third generation” studies.
•	 Basic studies that are focused on the investigation of 
features of immune response against CNPs. To date, no 
comprehensive investigations of this group have been 
performed, although in some studies the prevalence of 
CNP antigens and anti-CNP antibodies among various 
populations27 and under the various pathological condi-
tions has been analyzed.36,43,45,48 Further investigations of 
this group should denote the role of certain components 
of cellular and humoral arms of the immune response 
(for instance, the significance of various lymphocyte 
subsets and cytokines) in CNP-associated diseases. 
Similarly, the features of innate and adaptive immune 
response against CNPs should be defined, the regulation 
of CNP-induced immune response should be uncovered, 
the peculiarities of immunological memory against CNPs 
should be analyzed, and the possibilities of immunother-
apy of CNP-associated diseases may be investigated.
•	 Fundamental studies that are focused on the development 
of new methods of CNP identification and diagnostics 
of CNP-associated diseases (for instance, they should be 
directed to the extraction of new specific CNP antigens or 
new specific anti-CNP MoAbs, to the invention of new 
culture media, and also to the development of new stain-
ing methods). They could lead to a similar breakthrough 
in the field as was made after the studies of Kajander and 
Ciftçioglu,16 Kumar et al,22 and Shiekh et al,26 in which many 
new methods of working with CNPs were described.
•	 Experimental studies on animal models and epidemio-
logical studies that are focused on the uncovering of new 
connections between CNPs and the etiopathogenesis of 
various diseases, and also to the search, trial, and approba-
tion of new ways of treating CNP-associated diseases. To 
date, certain studies of this type have been successfully 
performed (as investigations on animal models23,26,31,34,38 
and as epidemiological studies16,22,25,32,33,36,37,39–49). Two 
papers indicate comET-therapy as a possible effective 
method of treatment of CNP-associated diseases.36,41 
Further studies certainly will lead to the discovery 
of new associations between CNPs and pathological 
conditions, and to the development of new methods of 
treatment of CNP-associated diseases. It is important 
to underline the necessity of increasing the sample size 
in future epidemiological investigations, since in the 
majority of studies to date, the sample sizes have been 
insufficient to accurately assess the significance of the 
apparent   connection. The combination of distinct meth-
ods (serological, bacterioscopic, and bacteriological) of 
CNP identification in biological samples is needed as 
well. This is also the case for the experiments on animal 
models, in which it is necessary to denote several groups 
to the study of features of mineralized and demineralized 
CNPs (as was done in the study of Schwartz et al31), and 
for the comparison of effects caused by CNPs with ones 
caused by hydroxyapatite crystals (as was done in the 
investigation of Wang et al23).
•	 Ecological, hygienic, and pharmacological studies that are 
focused on the prevention of CNP-associated diseases. 
To date, no such investigations have been conducted; 
however, studies by Shoskes et al36 and Maniscalco 
and Taylor41 point to the possible role of comET-ther-
apy for the purpose of chemoprevention. Obviously, 
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  development, approbation, and implementation of the 
preventive   measures against CNP-associated diseases 
should be the aims of future research.
Undoubtedly, basic, translational, and clinical inves-
tigations that will be carried out in the future will clarify 
the role of CNPs in biology and medicine and will enable 
significant progress in the theoretical and practical fields of 
these sciences.
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